Purification to homogeneity of a high molecular weight human B cell growth factor; demonstration of specific binding to activated B cells; and development of a monoclonal antibody to the factor.
about
Identification of a cDNA for a human high-molecular-weight B-cell growth factorAntigen-independent regulation of cytoplasmic calcium in B cells with a 12-kDa B-cell growth factor and anti-CD19.Spontaneously increased B cell growth factor and B cell differentiation factor activities in the synovial fluid of patients with rheumatoid arthritis.Activation of resting human B cells by helper T-cell clone supernatant: characterization of a human B-cell-activating factor.A case of human B cell leukemia that implicates an autocrine mechanism in the abnormal growth of Leu 1 B cells.Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia.A primer on cytokines: sources, receptors, effects, and inducersActivation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50The Bb fragment of complement factor B acts as a B cell growth factorIdentification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytesMolecular and cellular biology of eosinophil differentiation factor (interleukin-5) and its effects on human and mouse B cells.The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cellsInterleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2.Response of neoplasms of B cell lineage to the proliferative effects of B cell growth factor and the phorbol ester TPA.Mechanisms of alcohol-induced suppression of B-cell response.
P2860
Q24309517-FDF84824-E650-488B-906A-652C1D2AB4DCQ33560533-7F331059-D827-4CBB-9837-72A2C752AEC6Q33561681-88F3F8A3-23D4-4B36-ACB0-D8063338DB3EQ34380000-8D6CAB23-E96C-4202-BBC8-BD97EE6AF8CDQ34546763-F23B430C-2573-497A-87A2-3076128337E5Q34579417-CAEEEC19-378A-4663-961B-F52643AE9256Q35376246-4D16BEFB-E241-44A4-800A-491E0E407659Q35612157-C16ED488-3370-4C78-B2DB-A4E0E219602EQ36355469-1CB3F7B7-7CCC-49B0-B17B-C33A033A53C8Q36356764-D45F177D-A228-47FE-9C8A-F0DB965B854AQ39640095-6581498E-6593-4E26-8BEC-19B4D4C142D8Q41341172-5F8E32EB-BBCF-4041-94CE-E0F52E234E78Q42111797-3203F386-F2FE-43A0-A672-9D3359D2E2E4Q42769737-1694F82B-BE03-48EC-B558-4F265976D4FEQ44992595-AA80715C-6C51-455D-BB6F-6DFC062FCE44
P2860
Purification to homogeneity of a high molecular weight human B cell growth factor; demonstration of specific binding to activated B cells; and development of a monoclonal antibody to the factor.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Purification to homogeneity of ...... clonal antibody to the factor.
@ast
Purification to homogeneity of ...... clonal antibody to the factor.
@en
type
label
Purification to homogeneity of ...... clonal antibody to the factor.
@ast
Purification to homogeneity of ...... clonal antibody to the factor.
@en
prefLabel
Purification to homogeneity of ...... clonal antibody to the factor.
@ast
Purification to homogeneity of ...... clonal antibody to the factor.
@en
P2093
P2860
P356
P1476
Purification to homogeneity of ...... clonal antibody to the factor.
@en
P2093
Ambrus JL Jr
Jurgensen CH
P2860
P304
P356
10.1084/JEM.162.4.1319
P407
P577
1985-10-01T00:00:00Z